Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone

In previous studies we demonstrated that targeting the nuclear exporter protein exportin-1 (CRM1/XPO1) by a selective inhibitor of nuclear export (SINE) compound is a viable therapeutic strategy against Non-Hodgkin Lymphoma (NHL). Our studies along with pre-clinical work from others led to the evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Muqbil, Irfana, Aboukameel, Amro, Elloul, Sivan, Carlson, Robert, Senapedis, William, Baloglu, Erkan, Kauffman, Michael, Shacham, Sharon, Bhutani, Divaya, Zonder, Jeffrey, Azmi, Asfar S., Mohammad, Ramzi M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584550/
https://www.ncbi.nlm.nih.gov/pubmed/27693556
http://dx.doi.org/10.1016/j.canlet.2016.09.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584550/
https://www.ncbi.nlm.nih.gov/pubmed/27693556
http://dx.doi.org/10.1016/j.canlet.2016.09.016

Ejemplares similares